GSK signs a biomarker agreement with KineMed; Breath biomarkers could spot lung cancer;

> Biomarker company KineMed has signed a multiyear R&D collaboration with U.K.-based GlaxoSmithKline to find markers for muscle wasting, fibrosis and metabolic diseases. Press release

> A group of RNA-binding proteins might help track progression in Alzheimer's disease. Press release | Abstract

> A genetic variation linked to alcohol dependence could be a marker for the trait, as well as a target for treatment. Article

> The University of Oxford is using technology from Population Genetics to study gene variants and find biomarkers linked with myocardial infarction, diabetes and metabolic disease. Press release

> Companion Dx has gained a nonexclusive license to Epigenomics' DNA methylation biomarker Septin9 to develop a blood-based laboratory-developed test for colorectal cancer. Article

> bioTheranostics has expanded its Precis Precision Medicine biomarker profiles for non-small cell lung and colorectal cancers to 13 non-small cell lung and 7 colorectal cancer clinically relevant tumor biomarkers. Press release

And Finally… Dogs can smell lung cancer on people's breath, according to previous research; National Jewish Health and Metabolomx are looking for the breath biomarkers that make this possible. Press release

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.